successful-ipo-prompts-renewed-interest-in-us-listings

Successful IPO prompts renewed interest in US listings

As more Chinese companies move to list in the US, we talk to BoA-Merrill LynchÆs Jason Cox about the current trends and what the most recent listings suggest about near-term IPOs.

When Chinese online gaming company Changyou.com started the marketing for a US initial public offering in mid-March, at a time of very volatile markets, it was by no means a guaranteed success. Several US IPOs that had launched since the beginning of the year had been forced to withdraw before pricing due to the volatile market environment and a lack of investor interest, and when Changyou decided to have a go, only one US company had managed to complete a listing in 2009. The two most recent Chinese listings in the US, which took place in late July and early August last year before the financial crisis began in earnest, had also both been significantly downsized after launch as investors were nervous about committing money to untested newcomers. That nervousness resulted in several deals being either delayed or pulled in the US markets last summer.

Looking at Changyou specifically, some commentators noted that the company derives more than 90% of its revenues from a single game, Tian Long Ba Bu. While this is presently the third most popular online game in China there is no guarantee that the company will be able to repeat that success with its future products, they argued.

However, Changyou persevered and when the deal closed on April 1 it had attracted orders for 15 times the number of American depositary shares on offer, which allowed it to fix the price at the top of the range at $16 for a total deal size of $138 million (including the 15% overallotment option which was exercised four days after the debut). And, as if to prove that this success was no short-lived April fool's day joke, the share price surged 25% when the company started trading the following day. Since then, it has continued to edge higher, finishing at $38.70 on Monday -- up more than 140% from the IPO price -- after reaching a record close of $39.34 on June 4. While these gains have come amid a rebound in the general market, Changyou.com has significantly outperformed the 18.7% rise in the Nasdaq Composite index in the same period.

Having demonstrated that investors were prepared to put some of their cash to work again, Changyou.com also opened the door for a series of other IPOs in the US markets in April and May. So far, all six of these have been by US companies, although Chinese specialty chemicals manufacturer Chemspec International yesterday started the roadshow for a small IPO of about $65 million through Citi and Credit Suisse.

So what made Changyou succeed when several other listing candidates failed? And what will other companies have to offer to receive the same favourable response from investors?

Jason Cox, head of ECM for Asia-Pacific at Bank of America-Merrill Lynch, which acted as joint bookrunner for Changyou's IPO together with Credit Suisse, argues that the basic start for any successful IPO has to be a quality product. However, Changyou also benefitted from the fact that it was being spun off from Sohu.com, which is already listed in the US.

"The parent has a long relationship and great track record with investors and over the past many quarters it has met or exceeded expectations, which laid a great groundwork for the spinoff," Cox said in an interview with FinanceAsia. "The gaming business has always been a key piece of Sohu's business and revenues, so research reports have focused on it and investors have watched it develop and grow over the years. Because of that there is already a familiarity. That was pretty important in terms of getting immediate credibility and immediate momentum for the deal."

Tellingly, the only US IPO to be completed in the first quarter this year -- the $828 million listing of Mead Johnson Nutrition in February -- was in a very similar situation. The producer of baby milk formula, which was also brought to market by BoA-Merrill Lynch alongside Citi, Credit Suisse, J.P. Morgan and Morgan Stanley, was a spin-off from Bristol-Myers Squibb, a US-listed drug manufacturer that also has a strong track record both in terms of earnings and share price performance. And even though it was sold into a market that was still highly volatile, Mead Johnson's share price did head higher after listing and, by the time Changyou priced its deal, Mead Johnson was trading 16% above its IPO price.

Another key factor that helped ensure the success of the Changyou deal, according to Cox, was that the bookrunners were able to make sure that investors understood from the beginning that the deal would get done, in spite of the market volatility and the drought of new issuance success. That way they knew that it would be worth their while to take a closer look at the company and to do the research.

"By the time [the roadshow] hit the US we were covered and to be able to go out with that message was very important as the whole issue of 'do I spend time on this, is this thing real?' goes away immediately. You still had to get people comfortable with that in that market, I think."

Market activity since Changyou's debut has shown that there is still demand for companies that do not have the reputation of a well-known parent to rely on to catch investors' attention. However, we are still quite far from the days when investors were buying basically anything put before them in the anticipation of sharp gains on day one.

"I think similar to Changyou, even if it isn't a spin-off situation, a solid track record and a history of earnings stability and performance is critical," Cox said. "But investors are very willing to buy into proven stories and the amount of liquidity that we saw for [Changyou] was something that we hadn't seen for quite a while. Basically, cash levels were at an all time high, investors were actively looking for opportunities and were very willing to invest - but it had to be high-quality. Risk tolerance is obviously nowhere near where it was in the previous two years, but liquidity is even greater than before the financial crisis."

Cox has a good perspective on the issue since Merrill Lynch has been involved in the past six Chinese IPOs in the US, including all three deals that were completed in 2008. The overall market sentiment has clearly improved since the most recent two -- China Distance Education Holdings and China Mass Media International Advertising -- came to market in July/August but like other investment bankers Cox is well aware that a continuing rally in the secondary markets doesn't automatically mean that primary market issuance will meet with the same enthusiasm. For one, new listings do typically equal little known or "untested" companies that need more than a promising business plan to attract attention

"Changyou was a huge success, but it doesn't bring us back to the market of 2007 (a record year for Chinese IPOs in the US with 26 new listings). I think it demonstrates that the liquidity is there, the ability to complete is there and the successful aftermarket is there, but all of that is still dependent on an appropriate valuation," he noted.

To read the rest of this interview, please go to page 2.

Demand for Changyou was strong enough that the bookrunners decided to close the order books one day early. As with most ADR listings, the bulk of the demand (about 85%) came from the US, and aside from the usual mix of long-only funds, momentum investors and sector specialist funds, the order book also included a number of Sohu.com's existing investors who opted to buy a direct stake in the subsidiary in addition to their indirect holdings through Sohu.com. The parent still holds 68.5% of Changyou after the spin-off and controls just over 80% of the voting power.

While part of the strong demand was due to investors in general sitting on a lot of cash that they were ready to invest again after the six-month slump that followed after the Lehman Brothers bankruptcy - other US deals since confirm that this is indeed the case - Cox also argues that China in particular has a draw for US investors.

"China is still the only growth engine left and the expectation is also that when things improve, China is going to be one of the first economies to turn. Therefore people are much more willing to put money to work in China, I think, than in other markets - particularly other emerging markets," Cox said.

That said, there hasn't exactly been a flood of other Chinese issuers fighting to take advantage of the improved market sentiment in the US since Changyou kicked the door open. Aside from Chemspec, only one other company has flagged its intention for an IPO so far. Interestingly, this too is a spin-off from a company that is already listed in the US - in the online gaming sector. Shanda Interactive Entertainment said on May 25 that it planned to submit a draft registration on a confidential basis to the SEC for a "possible" IPO of Shanda Games in order to provide the subsidiary, which is currently wholly-owned, "with a sharper focus and greater flexibility to pursue strategic opportunities in enhancing its leadership position in the online games sector."

There is obviously a lag between when a company makes the decision to go for an IPO and the time it actually comes to market and according to bankers there were quite a few Chinese companies that put their listing plans on hold when the markets failed in the fourth quarter last year. Consequently, not many issuers were ready to go when the markets suddenly started to head higher again in mid-March.

"A lot of those companies are now re-evaluating whether or not they put their resources and efforts into preparing [for a listing] as there is a belief now that it might be worth the effort. Historically, one of the most active timeframes is around October/November and if companies started preparations in April/May, we will have a pretty busy fourth quarter."

Since foreign issuers can make their initial filings with the SEC on a confidential basis, it is difficult to assess how many companies intend to pursue a listing. However, if the pickup in IPO filings by US-based listing candidates is any indication, then confidence is definitely returning among first-time issuers. According to Dealogic, 10 companies have made such filings since the beginning of April, the largest of which is leaving its options open for a deal of up to $750 million.

Meanwhile, the liquidity and demand for Chinese stocks that became evident with Changyou's IPO has also sparked some follow-on and sell-down activity. These deals can be executed much more quickly and can therefore be timed to coincide with a strong day in the market. So far, solar cell manufacturer Suntech Power Holdings has raised $250 million from a follow-on arranged by UBS, Goldman Sachs and Deutsche Bank; while a pre-IPO investor in real estate agent E-House China Holdings sold part of its stake in a small $26 million block arranged by Credit Suisse.

Looking at the US market as a whole, May was a record month for follow-on issuance with $45.2 billion worth of share sales, according to Dealogic. This exceeded the previous monthly record of $26 billion in October 2008 by a significant margin, although volumes were somewhat inflated by the "forced" capital raisings in the financial sector (61% of the total) following the results of the government's "stress test". Wells Fargo and Morgan Stanley topped the list by raising $8.6 billion and $4.6 billion respectively.

"The US is a liquid market for follow-ons. I actually think that over the next few months, this is going to be more thematic than IPOs," concluded Cox.

US IPOs by Chinese companies
Month Issuer Size
($million)
Bookrunner
2009
April Changyou.com 138 BoA-ML/CS
2008
August China Mass Media 49 ML
July China Distance Education 61 Citi/ML
January ATA 48 ML
2007
December Gushan Environmental Energy 185 ML
December Xinyi Real Estate 282 ML
December Vane Info Technologies 75 Citi/ML
December ChinaEdu Corp 68 JPM
December VisionChina Media 114 CS/ML
December WSP Holdings 237 JPM
November China Nepstar Chain Drugstore 384 GS/ ML
November Agria Corp 283 CS
November AirMedia Group 259 BarCap/MS
October Giant Interactive Group 1,020 ML/UBS
October CNinsure 216 MS
October Longtop Financial Technologies 210 DB/GS
October Fugi International 73 Merriman
October Noah Education Holdings 159 DB
October China Digital TV Holding Co 221 CS/MS
August Wuxi PharmaTech 212 CS/JPM
August E-House (China) Holdings 232 CS/ML
July Perfect World 217 CS/MS
June Spreadtrum Communications 145 BarCap/MS
June Yingli Green Energy Holding 325 GS/UBS
May LDK Solar 486 MS/UBS
May China Sunergy 108 ML
May Acorn International 137 DB/ML
May Qiao Xing Mobile Communication 160 UBS
April Simcere Pharmaceutical Group 261 GS
March Tongjitang Chinese Medicines 102 ML/UBS
March Xinhua Finance Media 300 JPM/UBS
February JA Solar Holdings 259 Opp/PJ
February 3SBio 135 UBS
Source: Dealogic
¬ Haymarket Media Limited. All rights reserved.
Share our publication on social media
Share our publication on social media